Specific ACE2 expression in small intestinal enterocytes may cause gastrointestinal symptoms and injury after 2019-nCoV infection
The coronavirus disease 2019 (COVID-19) was first reported in Wuhan, China and rapidly spread in other countries in December 2019. The infected patients presented with fever, respiratory symptoms, sometimes with digestive and other systemic manifestations, and some progressed with a severe acute res...
Main Authors: | Hui Zhang, Hong-Bao Li, Jian-Rui Lyu, Xiao-Ming Lei, Wei Li, Gang Wu, Jun Lyu, Zhi-Ming Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-07-01
|
Series: | International Journal of Infectious Diseases |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971220302381 |
Similar Items
-
ACE2 in the Gut: The Center of the 2019-nCoV Infected Pathology
by: Yuexin Guo, et al.
Published: (2021-09-01) -
Corrigendum: ACE2 in the gut: The center of the 2019-nCoV infected pathology
by: Yuexin Guo, et al.
Published: (2022-10-01) -
A potential hypothesis for 2019-nCoV infection therapy through delivery of recombinant ACE2 by red blood cell-hitchhiking
by: Zahra Sadat Aghili, et al.
Published: (2020-12-01) -
Nursing management of 2019-nCoV pneumonia patients in Emergency Department
by: ZHANG Jing-min, GAO Yong-li
Published: (2020-04-01) -
Potential pharmacological candidates Transmembrane protease, serine 2 inhibitors 2019-ncov treatment
by: Alfredo Montes, et al.
Published: (2021-01-01)